In vivo simulation of human pharmacokinetics in the rabbit

Bulletin of Mathematical Biology

Volumn 60, Issue 3, 1998, Pages 545-567

  Bugnon, Denis ^a   Potel, Gilles ^a   Caillon, Jocelyne ^a   Baron, Denis ^a   Drugeon, Henri B ^a   Feigel, Philippe ^b   Kergueris, Marie F ^c  

^a UNIVERSITÉ DE NANTES   (France)

^b Centre Hospitalier Departemental   (France)

^c NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; TOBRAMYCIN;

ANIMAL; ANIMAL EXPERIMENT; BIOLOGICAL MODEL; BOLUS INJECTION; COMPARTMENT MODEL; CONTROLLED STUDY; CURVE FITTING; DOSE TIME EFFECT RELATION; DRUG CLEARANCE; DRUG HALF LIFE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MATHEMATICS; MOUSE; NONHUMAN; PHARMACOKINETICS; RABBIT; RAT; REVIEW;

EID: 0032077673     PISSN: 00928240     EISSN: None     Source Type: Journal    
DOI: 10.1006/bulm.1997.0013     Document Type: Article

References (14)

1. Bard, Y. (1974). Interpretation of the estimates, in Non linear parameter estimation, New York: Academic Press, pp. 170-217.
2. Boxenbaum, H. (1982). Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics. J. Pharmacokin. Biopharmacol. 10, 201-227.
3. Bugnon, D., G. Potel, Y. Q. Xiong, J. Caillon, M. F. Kergueris, P. Le Conte, D. Baron, and H. Drugeon (1996). In vivo antibacterial effects of simulated human serum profiles of once-daily versus thrice-daily dosing of amikacin in a serratia marcescens endocarditis experimental model. Antimicrobiol. Agents Chemother. 40, 1164-1169.
4. Craig, W. A., J. Redington and S. C. Ebert (1991). Phamacodynamics of amikacin in vitro and in mouse thigh and lung infections. J. Antimicrobiol. Ther. 27 (Suppl. C), 29-40.
5. Fantin, B., S. Ebert, J. Leggett, B. Vogelman and W. A. Craig (1990). Factors affecting duration of in-vivo postantibiotic effect for aminoglycosides against gram-negative bacilli. J. Antimicrobiol. Ther. 27, 829-836.
6. Fluckiger, U., P. Moreillon, J. Blaser, M. Bickle, M. P. Glauser and P. Francioli (1994). Simulation of amoxicillin pharmacokinetics in humans for the prevention of streptococcal endocarditis in rats. Antimicrobiol. Agents Chemother. 38, 2846-2849.
7. Gerber, A. U., H. P. Brugger, C. Feller, T. Stritzko and B. Stalder (1986). Antibiotic therapy of infections due to pseudomonas aeruginosa in normal and granulocytopenic mice: comparison of murine and human pharmacokinetics. J. Infect. Dis. 153, 90-97.
8. Jolley, M. E., S. D. Stroupe, C. H. J. Wang, H. N. Panas, H. L. Keegan, R. L. Schmidt and K. S. Schwenzer (1981). Fluorescence polarization immunoassay. I. Monitoring aminoglycoside antibiotics in serum and plasma. Clin. Chem. 27, 1190-1197.
9. Leggett, J. E., B. Fantin, S. Ebert, K. Totsuka, B. Vogelman, W. Calame, H. Mattie and W. A. Craig (1989). Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models. J. Infect. Dis. 159, 281-292.
10. Lindstrom, M. J. and D. M. Bates (1988). Newton-Raphson and EM algorithms for linear mixed-effects models for repeated-measures data. J. Am. Stat. Assoc. 83, 1014-1022.
11. Lindstrom, M. J. and D. M. Bates (1990). Nonlinear mixed effects models for repeated measures data. Biometrics 46, 673-687.
12. Mordenti, J. (1986). Man versus beast: pharmacokinetic scaling in mammals. J. Pharm. Sci. 75, 1028-1040.
13. Potel, G., J., Caillon, F. Le Gallou, D. Bugnon, P. Le Conte, J. Raza, J. Y. Lepage, D. Baron and H. Drugeon (1992). Identification of factor affecting in vivo aminoglycoside activity in an experimental model of gram-negative endocarditis. Antimicrobiol. Agents Chemother. 36, 744-750.
14. Van den Berg, C. L., J. R. McGiIl, J. G. Kuhn, J. T., Walsh, P. S. De la Cruz, K. K. Davidson, G. M. Wahl and D. D. Von Hoff (1994). Pharmacokinetics of hydroxyurea in nude mice. Anticancer Drugs, 5, 573-578.